| 000 | 01852 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516074542.0 | ||
| 264 | 0 | _c20120917 | |
| 008 | 201209s 0 0 eng d | ||
| 022 | _a1879-355X | ||
| 024 | 7 |
_a10.1016/j.ijrobp.2011.10.050 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChang, Jee Suk | |
| 245 | 0 | 0 |
_aHigh-dose helical tomotherapy with concurrent full-dose chemotherapy for locally advanced pancreatic cancer. _h[electronic resource] |
| 260 |
_bInternational journal of radiation oncology, biology, physics _cAug 2012 |
||
| 300 |
_a1448-54 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aChemoradiotherapy _xadverse effects |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 |
_aDeoxycytidine _xadministration & dosage |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOxonic Acid _xadministration & dosage |
| 650 | 0 | 4 |
_aPancreatic Neoplasms _xmortality |
| 650 | 0 | 4 | _aRadiotherapy Dosage |
| 650 | 0 | 4 |
_aRadiotherapy, Intensity-Modulated _xadverse effects |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aTegafur _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aGemcitabine |
| 700 | 1 | _aWang, Michael L C | |
| 700 | 1 | _aKoom, Woong Sub | |
| 700 | 1 | _aYoon, Hong In | |
| 700 | 1 | _aChung, Yoonsun | |
| 700 | 1 | _aSong, Si Young | |
| 700 | 1 | _aSeong, Jinsil | |
| 773 | 0 |
_tInternational journal of radiation oncology, biology, physics _gvol. 83 _gno. 5 _gp. 1448-54 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ijrobp.2011.10.050 _zAvailable from publisher's website |
| 999 |
_c21499157 _d21499157 |
||